Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: A randomized controlled study comparing the clinical outcome and safety; The AF-COR study

Europace

Volumn 15, Issue 11, 2013, Pages 1567-1573

  Malmborg, Helena ^a   Lönnerholm, Stefan ^a   Blomström, Per ^a   Blomström Lundqvist, Carina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Atrial fibrillation; Catheter ablation; Cryoballoon; Phased RF; PVAC; Quality of life

Indexed keywords

AMIODARONE;

ADULT; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; CRYOABLATION; ENERGY RESOURCE; FEMALE; FLUOROSCOPY; FOLLOW UP; GROIN HEMATOMA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAROXYSMAL ATRIAL FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; PHRENIC NERVE PARALYSIS; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; THYROTOXICOSIS; AGED; CATHETER ABLATION; CONTROLLED CLINICAL TRIAL; CRYOBALLOON; CRYOSURGERY; EQUIPMENT; HEART ATRIUM FIBRILLATION; HEART CATHETER; METHODOLOGY; PHASED RF; PULMONARY VEIN; PVAC; SWEDEN; TIME; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOBALLOON; PHASED RF; PVAC; QUALITY OF LIFE;

AGED; ATRIAL FIBRILLATION; CARDIAC CATHETERS; CATHETER ABLATION; CRYOSURGERY; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PULMONARY VEINS; QUALITY OF LIFE; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901841136     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut104     Document Type: Article

References (25)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
2. Boersma LV,Wijffels MC, Oral H,Wever EF, Morady F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with amultielectrode ablation catheter. Heart Rhythm 2008;5:1635-42.
3. Malmborg H, Lonnerholm S, Blomstrom-Lundqvist C. Acute and clinical effects of cryoballoon pulmonary vein isolation in patients with symptomatic paroxysmal and persistent atrial fibrillation. Europace 2008;10:1277-80.
4. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, NeuserHet al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008;52:273-8.
5. Van Belle Y, Janse P, Theuns D, Szili-Torok T, Jordaens L. One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace 2008;10:1271-6.
6. Kojodjojo P, O'Neill MD, Lim PB, Malcolm-Lawes L, Whinnett ZI, Salukhe TV et al. Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: Medium-term outcomes and nonrandomised comparison with pulmonary venous isolation by radiofrequency ablation. Heart 2010;96:1379-84.
7. Mulder AA, Wijffels MC,Wever EF, Boersma LV. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure. Europace 2012;14:818-25.
8. Bittner A, Monnig G, Zellerhoff S, Pott C, Kobe J, Dechering D et al. Randomized study comparing duty-cycled bipolar and unipolar radiofrequency with point-by-point ablation in pulmonary vein isolation. Heart Rhythm 2011;8:1383-90.
9. Bulava A, Hanis J, Sitek D, Osmera O, Karpianus D, SnorekMet al. Catheter ablation for paroxysmal atrial fibrillation: A randomized comparison between multielectrode catheter and point-by-point ablation. Pacing Clin Electrophysiol 2010;33:1039-46.
10. Beukema RP, Beukema WP, Smit JJ, Ramdat Misier AR, Delnoij PP,Wellens H et al. Efficacy of multi-electrode duty-cycled radiofrequency ablation for pulmonary vein disconnection in patients with paroxysmal and persistent atrial fibrillation. Europace 2010;12:502-7.
11. Namdar M, Chierchia GB,Westra S, Sorgente A, Meir ML, Bayrak F et al. Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon. Europace 2012;14:197-203.
12. Mulder AA, Wijffels MC,Wever EF, Boersma LV. Pulmonary vein anatomy and longterm outcome after multi-electrode pulmonary vein isolation with phased radiofrequency energy for paroxysmal atrial fibrillation. Europace 2011;13:1557-61.
13. Wieczorek M, Hoeltgen R, Brueck M, Bandorski D, Akin E, Salili AR. Pulmonary vein isolation by duty-cycled bipolar and unipolar antrum ablation using a novel multielectrode ablation catheter system: First clinical results. J Interv Card Electrophysiol 2010;27:23-31.
14. Klein G, Oswald H, Gardiwal A, Lusebrink U, Lissel C, YuHet al. Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm 2008;5:802-6.
15. Chun KR, Schmidt B, Metzner A, Tilz R, Zerm T, Koster I et al. The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: A prospective observational single centre study. Eur Heart J 2009; 30:699-709.
16. Herrera Siklody C, Arentz T, Minners J, Jesel L, Stratz C, Valina CM et al. Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: A randomized study comparing radiofrequency ablation with cryoablation. Heart Rhythm 2012;9:189-96.
17. Reynolds MR,Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010;3:615-23.
18. Wokhlu A, Monahan KH, Hodge DO, Asirvatham SJ, Friedman PA, Munger TM et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J Am Coll Cardiol 2010;55:2308-16.
19. Kuhne M, Suter Y, Altmann D, Ammann P, Schaer B, Osswald S et al. Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: Biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns. Heart Rhythm 2010;7:1770-6.
20. Linhart M, Bellmann B, Mittmann-Braun E, Schrickel JW, Bitzen A, Andrie R et al. Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: A case-control study. J Cardiovasc Electrophysiol 2009;20:1343-8.
21. Chierchia GB, de Asmundis C, Muller-Burri SA, Sarkozy A, Capulzini L, Paparella G et al. Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation: A prospective study. Europace 2009;11:445-9.
22. Ahmed H, Neuzil P, Skoda J, D'Avila A, Donaldson DM,LaragyMCet al. The permanency of pulmonary vein isolation using a balloon cryoablation catheter. J Cardiovasc Electrophysiol 2010;21:731-7.
23. Greef YD, Tavernier R, Schwagten B, KeulenaerGD, Stockman D, Duytschaever M. Impact of radiofrequency characteristics on acute pulmonary vein reconnection and clinical outcome after PVAC ablation. J Cardiovasc Electrophysiol 2013;24:290-6.
24. Van Belle Y, Janse PA, Groot NMS, Anné W, Theuns DAMJ, Jordaens LJ. Adenosine testing after cryoballoon pulmonary vein isolation improves long-term clinical outcome. Neth Heart J 2012;20:447-55.
25. Brunelli M, Raffa S, Grosse A,Wauters K, Menoni S, SchreiberMet al. Influence of the anatomic characteristics of the pulmonary vein ostium, the learning curve, and the use of a steerable sheath on success of pulmonary vein isolation with a novel multielectrode ablation catheter. Europace 2012;14:331-40.